Scarica l'app Stockscreener
1.60
4.19%
-0.07
Pre-mercato:
1.60
Precedente Chiudi:
$1.67
Aprire:
$1.68
Volume 24 ore:
2.31M
Relative Volume:
1.83
Capitalizzazione di mercato:
$306.72M
Reddito:
$156.37M
Utile/perdita netta:
$-37.49M
Rapporto P/E:
-7.619
EPS:
-0.21
Flusso di cassa netto:
$-47.77M
1 W Prestazione:
+1.91%
1M Prestazione:
+35.59%
6M Prestazione:
+29.03%
1 anno Prestazione:
-7.51%
Intervallo 1D:
$1.515
$1.68
Intervallo di 1 settimana:
$1.515
$1.70
Portata 52W:
$1.12
$2.235
Cerus Corp Stock (CERS) Company Profile
Nome
Cerus Corp
Settore
Industria
Telefono
(925) 288-6000
Indirizzo
1220 CONCORD AVENUE, CONCORD, CA
Confronta CERS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CERS
Cerus Corp
|
1.60 | 320.14M | 156.37M | -37.49M | -47.77M | -0.21 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Cerus Corp Stock (CERS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-04-12 | Iniziato | Craig Hallum | Buy |
| 2023-01-20 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-01-17 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2020-10-08 | Ripresa | BTIG Research | Buy |
| 2020-06-16 | Ripresa | Cantor Fitzgerald | Overweight |
| 2020-02-26 | Iniziato | BTIG Research | Buy |
| 2019-11-13 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2019-08-28 | Iniziato | Stifel | Buy |
| 2019-08-23 | Ripresa | Stephens | Overweight |
| 2018-01-05 | Ripresa | Cantor Fitzgerald | Overweight |
| 2017-12-08 | Ripresa | BTIG Research | Neutral |
| 2016-07-07 | Ripresa | Cantor Fitzgerald | Buy |
| 2015-12-17 | Downgrade | Wedbush | Outperform → Neutral |
| 2014-05-02 | Reiterato | MLV & Co | Buy |
| 2013-04-24 | Reiterato | Cantor Fitzgerald | Buy |
| 2013-03-15 | Reiterato | MLV & Co | Buy |
| 2012-04-17 | Iniziato | Cantor Fitzgerald | Buy |
| 2012-02-29 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2011-11-10 | Reiterato | MLV & Co | Buy |
| 2011-06-03 | Iniziato | Wedbush | Outperform |
| 2011-03-04 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2010-03-09 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2009-08-26 | Aggiornamento | Avondale | Mkt Perform → Mkt Outperform |
Mostra tutto
Cerus Corp Borsa (CERS) Ultime notizie
Why Cerus Corporation stock is popular among millennialsJuly 2025 Trade Ideas & Smart Swing Trading Techniques - newser.com
Wealth Enhancement Advisory Services LLC Acquires 27,092 Shares of Cerus Corporation $CERS - Defense World
What is the fair value estimate for Cerus Corporation (CU2) stock in 20252025 Price Targets & Free Verified High Yield Trade Plans - newser.com
Cerus Corporation stock trend forecastJuly 2025 Levels & Verified Chart Pattern Trade Signals - newser.com
What indicators show strength in Cerus CorporationMarket Trend Review & High Conviction Buy Zone Picks - newser.com
Can a trend reversal in Cerus Corporation lead to recoveryQuarterly Earnings Summary & Community Consensus Stock Picks - newser.com
Visualizing Cerus Corporation stock with heatmapsWeekly Gains Report & Verified Momentum Stock Alerts - newser.com
Weiss Ratings Reaffirms Sell (E+) Rating for Cerus (NASDAQ:CERS) - MarketBeat
What’s the recovery path for long term holders of Cerus CorporationJuly 2025 Weekly Recap & Fast Entry High Yield Stock Tips - newser.com
Cerus Corporation (NASDAQ:CERS) Short Interest Update - MarketBeat
What Fibonacci levels say about Cerus Corporation reboundJuly 2025 Weekly Recap & Low Risk Investment Opportunities - newser.com
Can Cerus Corporation stock sustain market leadershipQuarterly Profit Summary & Short-Term Trading Alerts - newser.com
Cerus (NASDAQ:CERS) Share Price Crosses Above 200 Day Moving Average – What’s Next? - Defense World
Will Cerus Corporation stock recover after recent drop2025 Fundamental Recap & AI Powered Trade Plan Recommendations - newser.com
What analysts say about Cerus Corporation CU2 stockCup and Handle Formations & Free Stay Ahead With Picks - earlytimes.in
What momentum indicators show for Cerus Corporation stockJuly 2025 Movers & Real-Time Volume Analysis - newser.com
Is Cerus Corporation CU2 a good long term investmentTechnical Analysis Insights & High Profit Investment Ideas - earlytimes.in
Cerus Corporation CU2 Stock Analysis and ForecastAutomated Trading Signals & Best Stocks For Explosive Growth - earlytimes.in
What drives Cerus Corporation stock priceGap Up/Gap Down Analysis & High Return Trading Tips - earlytimes.in
What recovery options are there for Cerus CorporationMarket Trend Summary & Daily Momentum Trading Reports - newser.com
Cerus And 2 Other Promising Penny Stocks To Watch - simplywall.st
Cerus Corp Azioni (CERS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cerus Corp Azioni (CERS) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Jensen Chrystal | Chief Legal Officer |
Mar 14 '25 |
Sale |
1.45 |
30,075 |
43,609 |
783,294 |
| Jensen Chrystal | Chief Legal Officer |
Mar 13 '25 |
Sale |
1.45 |
18,949 |
27,476 |
813,369 |
| Jayaraman Vivek K | Chief Operating Officer |
Mar 14 '25 |
Sale |
1.45 |
46,004 |
66,706 |
1,431,326 |
| Jayaraman Vivek K | Chief Operating Officer |
Mar 13 '25 |
Sale |
1.45 |
29,985 |
43,478 |
1,477,330 |
| Greenman William Mariner | President and CEO |
Mar 14 '25 |
Sale |
1.45 |
122,827 |
178,099 |
4,115,845 |
| Greenman William Mariner | President and CEO |
Mar 13 '25 |
Sale |
1.45 |
71,086 |
103,075 |
4,238,672 |
| Green Kevin Dennis | Chief Financial Officer |
Mar 14 '25 |
Sale |
1.45 |
36,740 |
53,273 |
875,867 |
| Green Kevin Dennis | Chief Financial Officer |
Mar 13 '25 |
Sale |
1.45 |
23,147 |
33,563 |
912,607 |
| Benjamin Richard J | Chief Medical Officer |
Mar 14 '25 |
Sale |
1.45 |
30,075 |
43,609 |
685,775 |
| Benjamin Richard J | Chief Medical Officer |
Mar 13 '25 |
Sale |
1.45 |
18,949 |
27,476 |
715,850 |
1.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):